LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer

This study is ongoing, but not recruiting participants.

Study NCT00010270. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00010270

Locations


Germany
	Universitaetsklinikum Freiburg
	Freiburg, Germany, D-79106

Sponsors and Collaborators

University Hospital Freiburg

National Cancer Institute (NCI)

Investigators


Study Chair:	Peter Hafkemeyer, MD	Kreiskrankenhaus Emmendingen